<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05031182</url>
  </required_header>
  <id_info>
    <org_study_id>RBHP 2021 CURINIER</org_study_id>
    <secondary_id>2021-A01218-33</secondary_id>
    <nct_id>NCT05031182</nct_id>
  </id_info>
  <brief_title>Tolerance of the vNOTES Surgical Technique in Total Hysterectomy for Benign Lesion. Clinical Trial of Non-inferiority Compared to the Laparoscopic Technique.</brief_title>
  <acronym>VLAP</acronym>
  <official_title>Tolerance of the vNOTES Surgical Technique in Total Hysterectomy for Benign Lesion. Clinical Trial of Non-inferiority Compared to the Laparoscopic Technique.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During a first consultation with an indication of total hysterectomy for a benign lesion, we&#xD;
      will study the patient's eligibility. After explanations of the study and submission of the&#xD;
      forms, the patient will benefit from a second consultation with the investigator to give her&#xD;
      consent. The surgeon will randomize the patient using RedCap computer software. The patient&#xD;
      will then be referred either to the vNOTES group or to the laparoscopy group. The surgery&#xD;
      will be performed by surgeons called &quot;expert&quot; in one of the ways first. For this, it will be&#xD;
      necessary to have performed at least 25 hysterectomies by laparoscopy or vNOTES. The surgery&#xD;
      will take place using the usual techniques. Per and postoperative complications will be&#xD;
      studied and noted up to six months postoperatively.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 11, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complications per or post Operative</measure>
    <time_frame>one month after surgery</time_frame>
    <description>Appearance of a per or post operative complication: bleeding, digestive or urinary sore or infection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure of pain</measure>
    <time_frame>Until one month</time_frame>
    <description>Quantification of postoperative pain: 6 hours, 24 hours, day 2, 5, 7, 14 and at one month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of operation</measure>
    <time_frame>one day</time_frame>
    <description>From skin opening to skin or vaginal closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of quality of life</measure>
    <time_frame>Six month</time_frame>
    <description>Respond to SF-36 questionnaire to assess and compare quality of life before and after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of satisfaction</measure>
    <time_frame>Six month</time_frame>
    <description>Respond to FSFI questionnaire to assess and compare sexuality before and after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of work stoppage</measure>
    <time_frame>one month</time_frame>
    <description>Patients will inquire if they needed to prolong the sick leave.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Hysterectomy</condition>
  <condition>Laparoscopy</condition>
  <condition>vNOTES</condition>
  <arm_group>
    <arm_group_label>Laparoscopy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In this Arm, patient will have the traditional hysterectomy by laparoscopy. This is the type of surgery that we realize everyday.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vNOTES</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this Arm, patient will have the hysterectomy by vNOTES (vaginal natural orifices Transluminal surgery). It's the new type of surgery that we want prove the no-inferiority.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopy</intervention_name>
    <description>The hysterectomy is performed by laparoscopy as described in the EMC.</description>
    <arm_group_label>Laparoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>vNOTES</intervention_name>
    <description>The hysterectomy is performed by vNOTES as described Dr BAEKELANDT and this team.</description>
    <arm_group_label>vNOTES</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult woman eligible for total hysterectomy for benign lesions with or without&#xD;
             bilateral adnexectomy.&#xD;
&#xD;
          -  Able to give informed consent to participate in research.&#xD;
&#xD;
          -  Affiliation to a Social Security scheme.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
&#xD;
          -  Contraindication to the laparoscopic approach&#xD;
&#xD;
          -  Contraindication to first vNOTES, in particular: virginity, history of rectal surgery,&#xD;
             rectovaginal endometriosis, high active genital infection&#xD;
&#xD;
          -  Indications for another concomitant surgical procedure (other than procedure on the&#xD;
             appendix)&#xD;
&#xD;
          -  Indication of hysterectomy for malignant lesion.&#xD;
&#xD;
          -  Any concomitant pathology deemed incompatible with the study.&#xD;
&#xD;
          -  COVID not cured or SARS-COv2 positivity dating less than 3 days before surgery.&#xD;
&#xD;
          -  Adult patient protected, under guardianship or curatorship or legal safeguard&#xD;
&#xD;
          -  Refusal of participation.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandra CURINIER</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lise Laclautre</last_name>
    <phone>334.73.754.963</phone>
    <email>promo_interne_drci@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU clermont-ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lise Laclautre</last_name>
    </contact>
    <investigator>
      <last_name>Sandra Curinier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH d'Issoire</name>
      <address>
        <city>Issoire</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>lise Laclautre</last_name>
    </contact>
    <investigator>
      <last_name>Cl√©ment Bruhat</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 25, 2021</study_first_submitted>
  <study_first_submitted_qc>August 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2021</study_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

